CHAPTER 147
HB 1410 - FINAL VERSION
30march00.....3891h
2000 SESSION
01/09
HOUSE BILL 1410
COMMITTEE: Health, Human Services and Elderly Affairs
This bill changes the membership of the joint health council and clarifies its duties.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
30march00.....3891h
00-2490
01/09
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand
AN ACT relative to the joint health council.
Be it Enacted by the Senate and House of Representatives in General Court convened:
147:1 Joint Health Council; Membership; Duties. Amend RSA 326-B:10-a, I-III to read as follows:
326-B:10-a Joint Health Council.
I.(a) The joint health council shall consist of [the following] 9 members as follows: [the chair of the board of nursing, or designee who shall be a member of the board of nursing; one advanced registered nurse practitioner who is a member of the board of nursing currently licensed to practice nursing under RSA 326-B, appointed by the chair of that board; the chair of the board of medicine, or designee who shall be a member of the board of medicine; 2 physicians currently licensed to practice medicine under RSA 329 and who have worked collaboratively with advanced registered nurse practitioners, appointed by the chair of that board, provided that one of the physicians is a member of the board of medicine; the chair of the board of pharmacy, or designee who shall be a member of the board of pharmacy; and one member of the board of pharmacy currently licensed to practice as a clinical pharmacist under RSA 318, appointed by the chair of that board] 3 licensed, practicing advanced registered nurse practitioners, appointed by the board of nursing; 3 licensed, practicing physicians, appointed by the board of medicine, who work with advanced registered nurse practitioners; and 3 licensed clinical pharmacists appointed by the board of pharmacy, who are practicing clinical pharmacists. In no case shall a member of the joint health council be a member of the member's respective board.
(b) The chairmanship of the council shall rotate annually among the [representatives] appointees of the respective boards. Clerical support shall be provided on a rotating basis among the boards.
(c) Members of the council shall be appointed for 3-year terms and shall serve no more than 2 terms.
II. The council shall meet not less than once every 3 months to discuss matters pertinent to the A.R.N.P. formulary and matters of mutual concern to the board of medicine, the board of nursing and the board of pharmacy, unless there are no agenda items. [Each of the 3 boards] Any council member may submit items to be assigned to the agenda for every meeting of the council. [Any items on the agenda not addressed at a particular council meeting shall be decided at the next meeting of the council.] Any council member may request that an item submitted for consideration by the council include relevant scientific information from recognized professional publications. A denial of a requested item or decision to further restrict a drug already approved shall be in writing and include relevant scientific information from recognized professional publications.
III. The duties of the joint health council shall include, but not be limited to, adding or altering the list of controlled and noncontrolled molecular entities on the A.R.N.P. formulary. Decisions on such additions or alterations shall be rendered within 3 months of initial consideration by the council unless there is a request for additional scientific information. [Any new controlled or noncontrolled molecular entities, in accordance with federal Food and Drug Administration provisions in 21 C.F.R. part 312, that are available after September 1, 1994, shall be considered for approval by the board upon petition by advanced registered nurse practitioners and approved for use by advanced registered nurse practitioners only after an affirmative vote of the joint health council]. Appeals of decisions of the council shall be submitted to the council in writing for further deliberation by the council. The A.R.N.P. formulary shall be updated at least annually and shall be available in paper and electronic format from the board of nursing, the board of medicine, and the board of pharmacy.
147:2 Effective Date. This act shall take effect 60 days after its passage.
(Approved: May 23, 2000)
(Effective Date: July 22, 2000)